1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter's Fiver Forces Analysis 36
3 Segmentation of North America Market by Vaccine Type 40
3.1 Market Overview by Vaccine Type 40
3.2 Live/Attenuated Vaccines 42
3.3 Inactivated Vaccines 43
3.4 Subunit Vaccines 44
3.5 Toxoid Vaccines 45
3.6 Conjugate Vaccines 46
3.7 Recombinant Vector Vaccines 47
3.8 Other Vaccines 48
4 Segmentation of North America Market by Disease 49
4.1 Market Overview by Disease 49
4.2 Vaccines for Pneumococcal Disease 51
4.3 Vaccines for Poliovirus 52
4.4 Vaccines for Hepatitis 53
4.5 Vaccines for Influenza 54
4.6 Vaccines for Measles, Mumps, and Rubella (MMR) 55
4.7 Vaccines for Varicella 56
4.8 Vaccines for Human Papilloma Virus 57
4.9 Vaccines for COVID-19 58
4.10 Vaccines for Other Diseases 59
5 Segmentation of North America Market by Administration 60
5.1 Market Overview by Administration 60
5.2 Intramuscular Route 62
5.3 Subcutaneous Route 63
5.4 Oral Route 64
5.5 Intravenous Injection 65
5.6 Other Administration Routes 66
6 Segmentation of North America Market by Patient 67
6.1 Market Overview by Patient 67
6.2 Pediatric Vaccines 69
6.3 Adult Vaccines 71
7 North America Market 2019-2026 by Country 73
7.1 Overview of North America Market 73
7.2 U.S. 76
7.3 Canada 81
7.4 Mexico 84
8 Competitive Landscape 87
8.1 Overview of Key Vendors 87
8.2 New Product Launch, Partnership, Investment, and M&A 90
8.3 Company Profiles 91
AstraZeneca plc 91
Bavarian Nordic A/S 93
China National Biotec Group Company Ltd. 94
CSL Ltd. 95
Daiichi Sankyo Co. Ltd 96
Emergent BioSolutions Inc. 97
GlaxoSmithKline PLC 98
Johnson & Johnson 99
Merck & Co. 100
Novavax, Inc. 101
Pfizer Inc. 102
Sanofi SA 103
Takeda Pharmaceutical Co. Ltd 104
9 Investing in North America Market: Risk Assessment and Management 105
9.1 Risk Evaluation of North America Market 105
9.2 Critical Success Factors (CSFs) 108
Related Reports and Products 111
?